Descrizione Clinica
Eosina pharma disinfectants thirty 2% 50g
EOSINA PHARMA TRENTA SKIN AND SUBCUTANEOUS USE
active ingredients
EOSINA PHARMA TRENTA – 1% cutaneous solution 100 g solution 1% contain Active ingredient: eosine 1 g. EOSINA PHARMA TRENTA 2% cutaneous solution 100 g 2% contain Active ingredient: eosine 2 g. For full list of excipients, see par. 6.1.Excellent
2–Bromo–2–Nitropropane–1,3–Diol, imidazolidinilurea, purified water.Therapeutic indications
Local treatment for the disinfection of small wounds, abrasions, burns, insect bites, diaper erythms, decubits and wounds in general.Contraindications
Hypersensitivity to the active ingredient or any of the excipients.Population
Apply 1 – 2 times a day some drops, using a clean gauze or pour directly on the area to be treated; possibly cover with an appropriate dry sterile bandage.Conservation
Store in closed container, sheltered from light.Warnings
Avoid application near the eyes. Eosina solution skin red color the skin; stains disappear in about three days. Important information about some excipients: None in particularInteractions
There are no known interactions with other drugs.Effects
Below are the undesirable effects of eosine, organized according to the organic systemic classification MedDRA. No sufficient data is available to determine the frequency of the individual effects listed. Immune system disorders – Hypersensitivity reactions Skin and subcutaneous tissue pathologies – Contact dermatitisOverdosing
There are no known toxic phenomena due to overdose.Since systemic absorption is negligible, there are no predictable negative effects for the fetus during pregnancy and for the child during breastfeeding.
Source: Farmadati
